MedPath

Meal Timing and Blood Pressure

Not Applicable
Completed
Conditions
Blood Pressure
Neurovascular Control
Interventions
Behavioral: Time-Restricted Feeding
Registration Number
NCT04133701
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

Brain blood flow, blood pressure, and neurovascular control mechanisms will be measured in middle-aged adults before and after a brief intervention period. The intervention will consist of changing the time in which the participant consumes food each day.

Detailed Description

Healthy adults experience a 10-20% decrease in night-time blood pressure, compared with day-time blood pressure. However, 20-40% of middle-aged adults do not demonstrate a decrease in blood pressure. Abnormal blood pressure patterns are linked to sleep disturbances, hypertension, and associated with elevated cardiovascular risk and mortality. Additionally, abnormal diurnal blood pressure patterns are associated with impaired neurovascular control of the circulation, contributing to an increased risk of hypertension, stroke, and cardiovascular disease. Importantly, midlife is the critical period for implementing interventions to prevent or delay future cardiovascular disease. Recent data demonstrates that time-restricted feeding may normalize blood pressure patterns. The overall goal of this study is to determine if time-restricted feeding normalizes blood pressure patterns and improves neurovascular control.

The research aims are:

1. To determine the effect of meal timing on blood pressure patterns in middle-aged adults.

2. To determine the effect of meal timing on neurovascular control in middle-aged adults.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • BMI ≤ 34 kg/m2
  • Non-smoking
  • Sedentary or recreationally active
  • ≤ 2 Alcoholic drinks per day
  • Female subjects: Perimenopausal/Postmenopausal
Exclusion Criteria
  • History or evidence of hepatic, renal, hematological, peripheral vascular disease, or stroke/neurovascular disease, diabetes, uncontrolled hypertension, sleep apnea
  • On medications used to treat/manage diseases listed above
  • Work overnight shifts
  • Clinically diagnosed anxiety or depression
  • Pregnant or trying to become pregnant
  • Significant surgical history
  • Other significant medical conditions at investigator's discretion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Time-Restricted FeedingTime-Restricted FeedingControl (Baseline): Blood pressure and neurovascular control will be measured. Post-Intervention: Blood pressure and neurovascular control will be measured.
Primary Outcome Measures
NameTimeMethod
Blood Pressure measured continuously over a period of 24 hourContinuously over a 24-hour period

Utilize an ambulatory blood pressure monitor to measure blood pressure values continuously over a 24-hour period.

Neurovascular Control: Change in the brain blood flowBaseline and 5 weeks

Change in brain blood flow will be measured using a transcranial Doppler ultrasound in response to a breathing test.

Neurovascular Control: Change in the blood pressureBaseline and 5 weeks

Change in blood pressure in response to a breathing test.

Neurovascular Control: change in the sympathetic nerve activityBaseline and 5 weeks

Change in sympathetic nerve activity will be measured using microneurography in response to a breathing test.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin-Madison

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath